Evolus, Inc.
EOLS· Nasdaq
Released Aug 2, 2023, after the close
10-Q filed Aug 2, 2023, 33 days after period end · 0001570562-23-000088
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $49.35M | $37.16M | $26.10M | $7.81M |
| Net Income | -$18.14M | -$23.47M | -$15.60M | -$21.13M |
| EPS Diluted |
Evolus, Inc. · CIK 1570562 · Engraved from SEC EDGAR
| -$0.32 |
| -$0.42 |
| -$0.31 |
| -$0.63 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.